Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Yonggang He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-8744-2761; OpenAlex author ID A5012588109. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Clinical efficacy and chemoresistance analysis of precision neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a prospective, single-arm pil… Co-author DOI 10.1097/js9.0000000000002342↗
  2. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study. Co-author DOI 10.4251/wjgo.v14.i9.1785↗
  3. Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p… Co-author DOI 10.21037/jgo-20-533↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaobing Huang · 3 shared papers, 2021–2025 · strength 0.58
  2. Yichen Tang · 2 shared papers, 2021–2022 · strength 0.32
  3. Lu Zheng · 1 shared paper, 2025 · strength 0.26
  4. Lu Zheng · 1 shared paper, 2022 · strength 0.16
  5. Lu Zheng · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.